Baxter International Inc Revenue Growth Rates (BAX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Baxter International Inc   (NYSE: BAX)
 

BAX's Revenue Growth by Quarter and Year

Baxter International Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BAX/growth
https://api.csimarket.com/api/v1/companies/BAX/fundamentals
https://api.csimarket.com/api/v1/companies/BAX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
BAX Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3,064.00
2nd Quarter June 3,045.00
1st Quarter March 2,701.00
FY 8,810.00

BAXs Annual Revenue
Baxter International Inc 's Revenue in the fiscal year 2025 $ 11,244.00 millions
Baxter International Inc 's Revenue in the fiscal year 2024 $ 10,636.00 millions
Baxter International Inc 's Revenue in the fiscal year 2023 $ 14,813.00 millions
Baxter International Inc 's Revenue in the fiscal year 2022 $ 15,113.00 millions
Baxter International Inc 's Revenue in the fiscal year 2021 $ 12,784.00 millions




BAX Revenue third quarter 2026 Y/Y Growth Comment
Baxter International Inc achieved in the third quarter 2026, above Company average Revenue improvement of 8.08% year on year, to $ 3,064.00 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 100 other companies have achieved higher Revenue growth. While Baxter International Inc ' s Revenue increase of 8.08% ranks overall at the positon no. 1985 in the third quarter 2026.


BAX Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 8.08 %
2nd Quarter June 8.36 %
1st Quarter March 2.9 %
FY   -

Financial Statements
Baxter International Inc 's third quarter 2026 Revenue $ 3,064.00 millions BAX's Income Statement
Baxter International Inc 's third quarter 2025 Revenue $ 2,835.00 millions Quarterly BAX's Income Statement


BAX Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 0.62 %
2nd Quarter June 12.74 %
1st Quarter March -9.18 %
FY (Year on Year)   -


Back to BAX Growth rate Comparisons >> Back to BAX Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #101
Healthcare Sector #294
Overall #1985

Revenue Y/Y Growth Statistics
High Average Low
25.83 % 2.01 % -41.96 %
 
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #101
Healthcare Sector #294
Overall #1985
Revenue Y/Y Growth Statistics
High Average Low
25.83 % 2.01 % -41.96 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Baxter International Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
14.52 % 0.65 % -46.27 %
(Dec 31 2013)  


BAX's III. Quarter Q/Q Revenue Comment
Baxter International Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.62% quarter on quarter, to $ 3,064.00 millions.

Within Medical Equipment & Supplies industry 69 other companies have achieved higher Revenue quarter on quarter growth. While Baxter International Inc 's Revenue growth quarter on quarter, overall rank is 1707.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #225
Overall #1707
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #70
Healthcare Sector #225
Overall #1707
Revenue Q/Q Growth Statistics
High Average Low
14.52 % 0.65 % -46.27 %
(Dec 31 2013)  


BAX's III. Quarter Q/Q Revenue Comment
Baxter International Inc achieved in the III. Quarter 2026 below company average Revenue growth of 0.62% quarter on quarter, to $ 3,064.00 millions.

Within Medical Equipment & Supplies industry 69 other companies have achieved higher Revenue quarter on quarter growth. While Baxter International Inc 's Revenue growth quarter on quarter, overall rank is 1707.


Baxter International Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 11,784.00
Y / Y Revenue Growth (TTM) 6.9 %
Year on Year Revenue Growth Overall Ranking # 3041
Seqeuential Revenue Change (TTM) 1.98 %
Seq. Revenue Growth (TTM) Overall Ranking # 3041


Cumulative Revenue growth Comment
Baxter International Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 6.9% year on year, to $ 11,784 millions if the fiscal year would have ended in Sep 30 2026.
Baxter International Inc 's trailing twelve months Revenue growth was higher than company's average 1.54% and higher than 6.14% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 1.98 % from $11555 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 1.54%.

In the Healthcare sector 456 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 3041, from total ranking in previous quarter at 3862.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 159
Healthcare Sector # 457
Overall # 3434

Revenue TTM Y/Y Growth Statistics
High Average Low
18.38 %
 1.54 %
-40.96 %
(Sep 30 2022)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 131
Sector # 360
S&P 500 # 2528
Cumulative Revenue growth Comment
Baxter International Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 6.9% year on year, to $ 11,784 millions if the fiscal year would have ended in Sep 30 2026.
Baxter International Inc 's trailing twelve months Revenue growth was higher than company's average 1.54% and higher than 6.14% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 1.98 % from $11555 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 1.54%.
The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 1.98 % increase from $11555 millions in the period from Jun 30 2026 to Sep 30 2025.

In the Healthcare sector 456 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 3041, from total ranking in previous quarter at 3862.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 159
Healthcare Sector # 457
Overall # 3434

Revenue TTM Y/Y Growth Statistics
High Average Low
18.38 %
1.54 %
-40.96 %
(Sep 30 2022)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 131
Sector # 360
S&P 500 # 2528




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BAX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Apyx Medical Corp14.09%$ 14.093 millions
Incyte Corporation14.00%$ 13.999 millions
Aurinia Pharmaceuticals Inc 13.93%$ 13.926 millions
Indivior Pharmaceuticals Inc 13.74%$ 13.738 millions
Cryoport inc 13.54%$ 13.535 millions
Neuronetics Inc 13.35%$ 13.350 millions
Royalty Pharma Plc13.26%$ 13.263 millions
Evolus Inc 13.23%$ 13.235 millions
Privia Health Group Inc 13.19%$ 13.187 millions
Biocryst Pharmaceuticals Inc 13.11%$ 13.110 millions
U S Physical Therapy Inc12.90%$ 12.898 millions
Maravai Lifesciences Holdings Inc 12.78%$ 12.781 millions
Alphatec Holdings Inc 12.67%$ 12.670 millions
Harmony Biosciences Holdings inc 12.61%$ 12.609 millions
Medicinova Inc 12.35%$ 12.355 millions
Bionano Genomics Inc 12.34%$ 12.339 millions
Viemed Healthcare Inc 12.18%$ 12.180 millions
Ufp Technologies Inc 12.15%$ 12.154 millions
Innovage Holding Corp 12.14%$ 12.135 millions
Vertex Pharmaceuticals Inc11.85%$ 11.845 millions
Sanara Medtech Inc 11.67%$ 11.668 millions
Lemaitre Vascular Inc 11.51%$ 11.508 millions
Pacs Group Inc 11.45%$ 11.454 millions
Ocugen Inc 11.36%$ 11.358 millions
Dexcom Inc 11.26%$ 11.263 millions
Elanco Animal Health Incorporated11.26%$ 11.258 millions
Koru Medical Systems Inc 11.19%$ 11.194 millions
Elite Pharmaceuticals Inc 11.11%$ 11.113 millions
Pro dex Inc 10.96%$ 10.955 millions
Nrc Health10.95%$ 10.954 millions


About Baxter International Inc Revenue Growth Rates (BAX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Baxter International Inc (CIK 10456).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-068278
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Baxter International Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.